Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases
Tóm tắt
Từ khóa
Tài liệu tham khảo
Okuda K, Ohtsuki T, Obata H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study on 850 patients. Cancer 56:918
Gilbert HA (1976) Metastases: incidence, detection and evaluation without histological confirmation. In: Weiss L (ed) Fundamentaln aspects of metastasis. American Elsevier, New York, pp 385–405
Seifert JK, Junginger T, Morris DL (1998) A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edimb 43:141–154
Curley SA, Izzo F, Delrio P et al (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 230:1–8
Popperl G, Helmberger T, Munzing W et al (2005) Selective internal radiation therapy with SIR-spheres in patients with non-resectable liver tumors. Cancer Biother Radiopharm 20:200–208
Goldberg RM, Sargent DJ, Morton RF et al (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23–30
Grothey A, Sargent D, Goldberg RM et al (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracilleucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22:1209–1214
Kato I, Severson RK, Schwartz AG (2001) Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data. Cancer 92:2211–2219
Gates VL, Atassi B, Lewandowski RJ et al (2007) Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors. Future Oncol 3:73–81
Breedis C, Young G (1954) The blood supply in neoplasms in the liver. Am J Pathol 30:969–977
Bienert M, McCook B, Carr BI et al (2005) 90Y microspheres treatment of unresectable liver metastases: changes in 18 F-FDG uptake and tumor size on PET/CT. Eur J Nucl Med Mol Imaging 32:778–787
Dawson LA, Normolle D, Balter JM et al (2002) Analysis of radiation induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810–821
Gray BN, Burton MA, Kelleher DK et al (1989) Selective internal radiation (SIR) therapy for treatment of liver metastases: Measurement of response rate. J Surg Oncol 42:192–196
Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5:649–655
Ariel IM, Pack GT (1967) Treatment of inoperable cancer of the liver by intraarterial radioactive isotopes and chemotherapy. Cancer 20:793–804
Ariel IM, Padula G (1978) Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radioactive isotopes. J Surg Oncol 10:327–336
Stribley KV, Gray BN, Chmiel RL et al (1983) Internal radiotherapy for hepatic metastases: the homogeneity of hepatic arterial blood flow. J Surg Res 34:17–24
Grady ED, Sale WT, Rollins LC (1963) Localization of radioactivity by intravascular injection of large radioactive particles. Ann Surg 157:97–114
Nolan T, Grady ED, Crumbley AJ (1973) Regional internal radiation for hepatic cancer. Minerva Oncol 1:104–106
Nolan T, Grady ED, Crumbley AJ et al (1975) Internal hepatic radiotherapy: I. Organ distribution of colloidal Cr32 PO4 injected into a peripheral vein, the portal vein, or the arterial supply of the gastrointestinal tract in the rat. Am J Roentgenol Radium Ther Nucl Med124:590–595
Grady ED, Nolan T, Larose JH et al (1975) Internal hepatic radiotherapy: II. Intra-arterial radiocolloid therapy for hepatic tumors. Am J Roentgenol Ther Nucl Med 124:596–599
Ariel IM (1965) Treatment of inoperable primary pancreatic and liver cancer by the intraarterial administration of radioactive isotopes (Y-90 radiating microspheres). Ann Surg 162:267–278
Mantravadi RV, Spigos DG, Tan WS et al (1982) Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 142:783–786
Blanchard RJW (1983) Treatment of liver tumours with yttrium-90 microspheres. Can J Surg. 26:442–443
Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412–425
Jakobs TF, Hoffmann RT, Dehm K et al (2008) Hepatic yttrium-90 radioembolization of chemotherapyrefractory colorectal cancer liver metastases. J Vasc Interv Radiol 19:1187–1195
Mancini R, Carpanese L, Sciuto R et al (2006) A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIRspheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates. In Vivo 20(6A):711–714
Coldwell DM, Kennedy AS, Nutting CW (2007) Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 69:800–804
Jakobs TF, Hoffmann RT, Fischer T et al (2008) Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 19:683–690
Sato KT, Lewandowski RJ, Mulcahy MF (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres-safety, efficacy, and survival. Radiology 247:507–515
Park JO, Lee SI, Song SY et al (2003) Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol 33:533–537
Atassi B, Bangash A, Bahrani A et al (2008) Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics 28:81–99
Wong C, Qing F, Savin M et al (2005) Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F] fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol 16:1101–1106
Kwee TC, Takahara T, Ochiai R et al (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18:1937–1952
Stubbs RS, O’Brien I, Correia MM (2006) Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: singlecentre experience with 100 patients. ANZ J Surg 76:696–703
Sato K, Lewandowski R, Bui J et al (2006) Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (Thera-Sphere®): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29:522–529
Salem R, Thurston K (2006) Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies part 2: special topics. J Vasc Interv Radiol 17:1425–1439
Goin J, Dancey J, Roberts C et al (2004) Comparison of postembolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: transcatheter arterial chemo-embolization versus yttrium-90 glass microspheres. World J Nucl Med 3:49–56
Gulec SA, Siegel JA (2007) Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres. J Nucl Med 48:2080–2086
Gulec SA (2008) Combining SIRspheres with first — or second- line chemotherapy for colorectal cancer: initial results. 2nd European Symposium on liver directed cancer therapy using microspheres, Roma 9–10 Feb 2008